Please ensure Javascript is enabled for purposes of website accessibility
Contact us Contact Us
EN
Home > Featured Products > Oncology Research > Melanoma

960 product results for "Melanoma"

Options+
Options
Confirm
  • Product types
    0 selected
    Antibodies (298)
    Stable Cell Lines (1)
    Assay Kit (419)
    Proteins (75)
    Biosimilars (1)
    Research Biosimilar (157)
  • Expression system
    0 selected
    E. coli (35)
    Mammalian Cells (186)
    HEK293T (1)
  • Target
    0 selected
    Zenocutuzumab (1)
    Glofitamab (1)
    Guselkumab (3)
    ATP7B (1)
    Benufutamab (1)
    Amatuximab (1)
    Tregalizumab (1)
    PD-L1 & TGF-Beta (1)
    NP/Nucleocapsid (5)
    dsDNA (1)
    Astegolimab (1)
    Adalimumab (3)
    Tiragolumab (2)
    Labetuzumab (1)
    Obiltoxaximab (1)
    BSA (1)
    RBD (E484K) (1)
    Alacizumab (1)
    Faricimab (1)
    Nivolumab (3)
    Atezolizumab (3)
    Sotrovimab (1)
    MLANA (4)
    Edrecolomab (1)
    gD/Envelope glycoprotein D (1)
    Urelumab (1)
    Canakinumab (1)
    LAG-3 & PD-1 (1)
    Ganitumab (1)
    A29L (6)
    Mirvetuximab (1)
    B6R/SL-159 (1)
    CD274/PD-L1/B7-H1 (5)
    Necitumumab (1)
    Bimekizumab (1)
    TRP-1 & CD3e (1)
    S100P (1)
    CD223/LAG3 & CD152/CTLA4 (1)
    S100A10 (4)
    Lintuzumab (1)
    CD274/PD-L1 & CD47/MER6 (1)
    CD274/PD-L1 & SLT-Ia (1)
    CD80/B7-1 (20)
    Oxelumab (1)
    Panitumumab (3)
    Ixekizumab (1)
    Siltuximab (3)
    Suvizumab (1)
    CD47/MER6 & PDCD1 / PD-1 & CD137/4-1BB/TNFRSF9 (1)
    Ibritumomab (1)
    RBD (Omicron/BA.4/BA.5) (1)
    CD278/ICOS (1)
    Itolizumab (1)
    TPP15 (1)
    Anetumab (1)
    Zanolimumab (1)
    Blosozumab (1)
    Lacnotuzumab (1)
    Iscalimab (1)
    Olaratumab (1)
    Glycoprotein (5)
    PMEL17/ME20M (9)
    Protein A (1)
    Tisotumab (1)
    RBD (Kappa) (1)
    Ramucirumab (1)
    Nesvacumab (1)
    Pembrolizumab (3)
    mitF/aspF1 (1)
    Milatuzumab (1)
    Avelumab (3)
    Befovacimab (1)
    Casirivimab (1)
    Bimagrumab (1)
    gC/Envelope glycoprotein C (1)
    Utomilumab (1)
    Gevokizumab (1)
    Tezepelumab (1)
    Teprotumumab (1)
    IL6 (1)
    Bevacizumab (3)
    SARS-CoV-2 Neutralization Antibody (3)
    Ivuxolimab (1)
    PDL1 & VEGF (1)
    HLA-A2-peptide (TDQVPFSV) Complex (1)
    Ieramilimab (1)
    CD274/PD-L1 & VEGFA (1)
    TYRP1 (3)
    CD19 & PD-L1 & CD3E & CD137 (1)
    S100A9 (4)
    Asp f 1/mitF (1)
    CD274/PD-L1 & CD134/OX40 (1)
    CD274/PD-L1 & CD28 & CD152/CTLA4 (1)
    CD47/MER6 & CD274/PD-L1 (2)
    S100A16 (1)
    Pogalizumab (1)
    Serclutamab (1)
    Remtolumab (1)
    Clazakizumab (1)
    Mosunetuzumab (1)
    TPP17 (1)
    Conatumumab (1)
    Romosozumab (1)
    TYR (1)
    Romiplostim (2)
    Tovetumab (1)
    M/Matrix protein (2)
    CD3E (1)
    Belantamab (1)
    PD-L1 / VEGF-A (1)
    Certolizumab (2)
    Enoblituzumab (1)
    Cabiralizumab (1)
    Gremubamab (1)
    Human β Amyloid (1-42) (1)
    RBD (Delta Plus) (1)
    Spike glycoprotein (RBD) (1)
    Vanucizumab (1)
    Sintilimab (1)
    Glycoprotein G (2)
    Durvalumab (3)
    CD80&IL2 (1)
    Concizumab (1)
    Imdevimab (1)
    CD117/KIT (24)
    Rolinsatamab (1)
    gC/UL44 (1)
    Magrolimab (1)
    CD20/MS4A1 (3)
    Etanercept (3)
    Brolucizumab (1)
    RBD (Omicron/BA.5) (3)
    HLA-A2-peptide (ITDQVPFSV) Complex (4)
    EGFR & CD3E & PD-L1 & 4-1BB (1)
    CD366/TIM-3 & CD274/PD-L1 (1)
    TRP-1 & CD47/MER6 (1)
    CD274/PD-L1 & CD279/PD-1 (1)
    Oleclumab (1)
    IDO1 (2)
    CD366/TIM-3 & CD279/PD-1 (2)
    Sarilumab (2)
    CD152/CTLA4 & CD279/PD-1 (1)
    Ranibizumab (3)
    NP/Nucleoprotein (3)
    Tavolimab (1)
    Secukinumab (2)
    Imlifidase (5)
    Olokizumab (1)
    Foravirumab (1)
    CD47/MER6 & CD274/PD-L1/B7-H1 (2)
    Ocaratuzumab (1)
    Elotuzumab (1)
    Cusatuzumab (1)
    TPP47 (1)
    Drozitumab (1)
    Ontamalimab (1)
    Eldelumab (1)
    Sacituzumab (1)
    Eculizumab (3)
    Varlilumab (1)
    Tirzepatide (2)
    gp100 peptide-HLA Complex (1)
    Teclistamab (1)
    Mirzotamab (1)
    CD223 (1)
    Emactuzumab (1)
    M1R (5)
    Human β Amyloid (1-40) (1)
    Imalumab (1)
    Semaglutide (2)
    Ascrinvacumab (1)
    TFF3 (1)
    Tislelizumab (1)
    Disitamab (1)
    Pacmilimab (1)
    TDP2 (1)
    Marstacimab (1)
    Daratumumab (3)
    gD/US6 (1)
    Basiliximab (1)
    Elezanumab (1)
    Apamistamab (1)
    HLA-A2-peptide (YLEPGPVT) Complex (4)
    Calprotectin (S100A8/9) (3)
    BRAF/B-Raf (5)
    Mavezelimab (1)
    CD137/4-1BB & CD274/PD-L1 (3)
    TRP-1 & CD134/OX40 (1)
    CD274/PD-L1 & TGFBR2/TGFR-2 (1)
    CD80/B7-1 & CD86/B7-2 (2)
    S100A11 (2)
    RBD (6)
    Varisacumab (1)
    RBD (Omicron/JN.1) (1)
    Lirilumab (1)
    CTLA4 & PD1 (2)
    Tesidolumab (1)
    Sirukumab (1)
    Rafivirumab (1)
    cAMP (1)
    RBD (WT) (1)
    Vorsetuzumab (1)
    G/Major surface glycoprotein G (1)
    Lexatumumab (1)
    Mirikizumab (2)
    PDL1 (6)
    Aflibercept (1)
    Ipilimumab (2)
    GP/Envelope glycoprotein (4)
    T3E (1)
    Golimumab (3)
    Omburtamab (1)
    TAU pT181 (1)
    Evolocumab (1)
    EPO/Erythropoietin (1)
    Lupartumab (1)
    Toripalimab (1)
    Exenatide acetate (2)
    Pertuzumab (3)
    CD137/4-1BB/TNFRSF9& CD274/PD-L1/B7-H1 (1)
    Denosumab (3)
    US8/gE (1)
    Sibrotuzumab (1)
    Fluorescein & CD274/PD-L1 (1)
    Camidanlumab (1)
    Mazdutide (2)
    Omalizumab (2)
    HLA-A2-peptide (KTWGQYWQV) Complex (2)
    Favezelimab (1)
    CD86/B7-2 (26)
    CD152/CTLA4 & CD274/PD-L1 (1)
    Zampilimab (1)
    NRAS (2)
    CD175/Tn (10)
    S100A6 (1)
    LAG3 & PD-1 (1)
    Daclizumab (1)
    Enfortumab (1)
    Emibetuzumab (1)
    RBD (Delta) (3)
    FLT1/VEGFR1 & CD274/PD-L1 (1)
    RBD (Omicron/KP.2) (1)
    Tibulizumab (1)
    Ziltivekimab (1)
    VASH2/Vasohibin-2 (1)
    Carlumab (1)
    RBD (Alpha) (1)
    N/Nucleoprotein (1)
    Tigatuzumab (1)
    Glembatumumab (1)
    Lenzilumab (1)
    Semorinemab (1)
    Talacotuzumab (1)
    S100A5 (4)
    Tremelimumab (1)
    gG/US4 (2)
    T-cell surface antigen T3/Leu-4 epsilon chain (1)
    Pasotuxizumab (1)
    TIGIT & CD274/PD-L1 (1)
    Cixutumumab (1)
    H3L (3)
    TAU pT217 (1)
    Andecaliximab (1)
    Alirocumab (1)
    Cinpanemab (1)
    CD274/PD-L1 & CD28 (1)
    TYR/Tyrosinase (2)
    Trastuzumab (2)
    Nirsevimab (1)
    CD47/MER6 & PDCD1 / PD-1 / CD279 (1)
    Obinutuzumab (2)
    Cetuximab (3)
    Ifabotuzumab (1)
    CD366/HAVCR2/TIM-3 (4)
    Spike glycoprotein E2 (2)
    Simlukafusp Alfa (1)
    S100a15a (1)
    CD152/CTLA4 & CD134/OX40 (1)
    Rituximab (1)
    CD274/PD-L1 & CD137/TNFRSF9 (1)
    S100A12 (1)
    S100A14 (1)
    CD274/PD-L1 (81)
    Anifrolumab (1)
    Spike glycoprotein E1 (2)
    Spike glycoprotein (10)
    Crizanlizumab (1)
    CD340/ERBB2 (1)
    Codrituzumab (1)
    Tanezumab (1)
    Vunakizumab (1)
    Tosatoxumab (1)
    SOX10 (3)
    RBD (Beta) (1)
    Meplazumab (1)
    Balstilimab (1)
    Namilumab (1)
    Dilpacimab (1)
    Tilavonemab (1)
    Natalizumab (2)
    S100A8 (3)
    Vibecotamab (1)
    Zalifrelimab (1)
    gB/Envelope glycoprotein B (1)
    T-cell surface glycoprotein CD3 epsilon chain (1)
    Rosopatamab (2)
    Infliximab (2)
    Frovocimab (1)
    Dalotuzumab (1)
    E8L (5)
    S100A2 (1)
    Depatuxizumab (1)
    Retatrutide (1)
    Zanidatamab (1)
    Palivizumab (3)
    KITLG/SCF (1)
    Afutuzumab (1)
    sCD14 (1)
    CD366/TIM-3 (34)
    Abatacept (1)
    S100A13 (1)
    S100A4 (3)
    CD274/PD-L1 & CD152/CTLA4 (1)
    Indatuximab (1)
    S100B (9)
    CD223/LAG3 (41)
    CD279/PD-1 & CD274/PD-L1 (1)
    CD137/4-1BB & CD274/PD-L1 & ROR1 & CD3 (1)
    S100A1 (2)
    Vofatamab (1)
    CD223/LAG3 & CD279/PD-1 (4)
    Epcoritamab (1)
    F/Fusion glycoprotein F0 (5)
    Letolizumab (1)
    dsRNA (1)
    Ibalizumab (1)
    Ianalumab (1)
    Tocilizumab (3)
    Spike Protein (Trimer) (2)
    Dupilumab (3)
    Inclacumab (1)
    IL1RL1/ST2 (1)
    VSIR/VISTA & CD274/PD-L1 (1)
    Cergutuzumab (1)
    cGMP (1)
    Lorvotuzumab (1)
    RBD (Gamma) (1)
    MITF (1)
    Cetrelimab (1)
    DCT (2)
    Otilimab (1)
    Navicixizumab (1)
    VEGFA & B7-H1 / PD-L1 / CD274 (1)
    Zagotenemab (1)
    gE/Envelope glycoprotein E (1)
    Tarextumab (1)
    Lodelcizumab (1)
    PD-L1 & VEGF (1)
    Figitumumab (1)
    A35R (5)
    Farletuzumab (1)
    Ustekinumab (3)
    CD79B (2)
    Losatuxizumab (1)
    Afasevikumab (1)
    β-D-Glucan (1)
    Suptavumab (1)
    B7-H1 / PD-L1 / CD274 & CD3E (1)
    Icrucumab (1)
    CD152/CTLA4 (86)
    CD274/PD-L1 & TGFBR2 (1)
    CD279/PD-1 & CD152/CTLA4 (4)
    CD274/PD-L1 & CD3E (1)
    p-Tyr (1)
  • Species
    0 selected
    Felis catus (Cat) (9)
    Cat (1)
    Mouse (27)
    Canis lupus familiaris (1)
    Rat (1)
    Neosartorya fumigata (1)
    Tupaia chinensis (12)
    Mus musculus (Mouse) (7)
    Canis lupus familiaris (Dog) (8)
    Homo sapiens (Human) (7)
    Dog (3)
    Human (178)
  • Applications
    0 selected
    SPR (4)
    Bioactivity: FACS (153)
    in vivo PD-L1 blockade (3)
    IP (2)
    SDS-PAGE (75)
    Bioactivity: FACS (1)
    Functional assay (158)
    in vitro PD-L1 blockade (3)
    FACS (5)
    Immunogen (75)
    Research in vivo (158)
    IHC-F (3)
    IF (8)
    Functional assay (6)
    Bioactivity testing in progress (31)
    Research in vivo (4)
    Neutralization (2)
    Blocking (2)
    in vivo CTLA-4 neutralization (2)
    ELISA (844)
    GICA (2)
    in vivo (2)
    in vivo intra-tumoral regulatory T cell depletion (2)
    in vivo blockade (2)
    Neut (1)
    FCM (152)
    IHC (84)
    FuncS (18)
    Inhib (1)
    WB (165)
    IFA (4)
  • Reactivity
    0 selected
    B7-H1 / PD-L1 / CD274 (1)
    Rhesus macaque (1)
    Mus musculus (Mouse) (1)
    Capra hircus (1)
    Oryzias latipes (1)
    Danio rerio (1)
    Broad-Spectrum (1)
    Xenopus laevis (1)
    Macaca mulatta (1)
    Drosophila grimshawi (1)
    Bovine (1)
    Rat (16)
    Drosophila willistoni (1)
    Neosartorya fumigata (1)
    Homo sapiens (Human) (4)
    Monkey (5)
    Kirsten murine sarcoma virus (1)
    Cat (1)
    Kryptolebias marmoratus (1)
    Avian retrovirus IC10 (1)
    Chicken (4)
    Limanda limanda (1)
    Avian rous-associated virus type 1 (1)
    Carassius auratus (1)
    Tupaia chinensis (4)
    Pig (6)
    Mesocricetus auratus (1)
    Bos taurus (8)
    Coturnix japonica (1)
    Cavia porcellus (1)
    Mouse (78)
    Cynomolgus monkey (1)
    Dog (13)
    Human (198)
    Callithrix jacchus (1)
    Monodelphis domestica (1)
    Oryctolagus cuniculus (4)
    Pongo abelii (2)
    Cyprinus carpio (1)
  • Host species
    0 selected
    Rabbit (61)
    Armenian Hamster (5)
    Chimeric (5)
    Rat (14)
    Humanized (34)
    Alpaca (6)
    HEK293T (1)
    Human (157)
    Dog (2)
    Mouse (164)
  • Clonality
    0 selected
    Polyclonal (53)
    Monoclonal (398)
  • Conjugate
    0 selected
    Unconjugated (301)
    PE (28)
    FITC (28)
    APC (28)
    PerCP (28)

Quick access

Contact Us

  • +86-27-65523339

  • info@abinscience.com

  • Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China

  • linkedin
  • Ins
  • youtube
  • youtube
Copyright © 2026 abinScience. All Rights Reserved. All Products are for Research Use Only